Physician

Adesola Awomolo, MD

According to 2025 Medicare claims, Adesola Awomolo, MD (NPI: 1699778894) practices medical oncology in the Sebastian-Vero Beach-West Vero Corridor, FL market, with the plurality of this provider's patient population coming from Indian River, FL. This provider's primary affiliated billing organization is INDIAN RIVER HEALTH SERVICES INC (NPI: 1588298285; TIN: 650029298) and primary practice location at 32960-4048. Awomolo is affiliated with the Duke Connected Care, LLC (ACO ID: A2419) and Cleveland Clinic Florida Integrated Health (ACO ID: A3588), participating under the MSSP model.

Awomolo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 342 traditional Medicare patients, billed 1,308 HCPCS/CPT codes, and received $105,260 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 1,347 prescription claims across 314 beneficiaries totaling $2,424,076 in drug costs, led by Ibrance (Palbociclib). 2023 DME data shows 33 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $1,869,882 to $105,260. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,033,320 and ending at $2,424,076. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $9,294 and ending at $2,974.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	575	177,972	$1,869,882
2016	574	163,837	$2,166,827
2017	606	135,533	$1,675,389
2018	569	162,621	$1,638,716
2019	590	136,260	$1,527,741
2020	269	985	$70,980
2021	273	1,117	$96,241
2022	335	1,303	$112,017
2023	356	886	$78,414
2024	342	1,308	$105,260

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	125	1,706	$1,033,320
2016	135	1,585	$1,220,118
2017	116	1,300	$1,342,733
2018	143	1,402	$1,288,895
2019	175	1,119	$1,057,023
2020	201	959	$712,571
2021	182	1,208	$1,568,234
2022	204	1,152	$1,225,730
2023	254	1,038	$789,724
2024	314	1,347	$2,424,076

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	16	114	$10,042
2016	18	95	$5,358
2017	26	163	$7,693
2018	11	101	$5,572
2019	N/R	55	$3,270
2020	36	402	$36,964
2021	N/R	184	$8,579
2022	N/R	44	$2,581
2023	N/R	33	$2,661
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	94	94	$145
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	263	643	$112
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	36	51	$90
G2212	Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or	194	342	$25
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	116	141	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ibrance	Palbociclib	27	756	$455,387
Cabometyx	Cabozantinib S-Malate	12	360	$352,094
Alunbrig	Brigatinib	12	360	$239,652
Tagrisso	Osimertinib Mesylate	13	390	$230,303
Inlyta	Axitinib	13	390	$192,656

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Adesola Awomolo, MD?

Tedicare shows public-source Medicare data for Adesola Awomolo, MD (NPI 1699778894), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adesola Awomolo, MD have ACO affiliation data?

Adesola Awomolo, MD is shown with ACO affiliation data for Duke Connected Care, LLC (MSSP, ACO ID A2419) and Cleveland Clinic Florida Integrated Health (MSSP, ACO ID A3588).

What billing organization is linked to Adesola Awomolo, MD?

Adesola Awomolo, MD is linked to INDIAN RIVER HEALTH SERVICES INC (billing NPI 1588298285) in the available physician profile data.

Does Adesola Awomolo, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.